Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 50.34
(-0.57%)
CNY 50.34
(-0.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 194.75 Million CNY | 54.14% |
| 2022 | 126.35 Million CNY | 13930.88% |
| 2021 | 900.52 Thousand CNY | -61.52% |
| 2020 | 2.34 Million CNY | -76.6% |
| 2019 | 10 Million CNY | -47.37% |
| 2018 | 19 Million CNY | 153.33% |
| 2017 | 7.5 Million CNY | 1701.15% |
| 2016 | 416.4 Thousand CNY | -36.88% |
| 2015 | 659.7 Thousand CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 176.34 Million CNY | -16.1% |
| 2024 Q1 | 210.19 Million CNY | 7.93% |
| 2024 Q3 | 216.43 Million CNY | 22.73% |
| 2023 Q4 | 194.75 Million CNY | 37.04% |
| 2023 FY | 194.75 Million CNY | 54.14% |
| 2023 Q2 | 155.1 Million CNY | 11.39% |
| 2023 Q1 | 139.24 Million CNY | 10.21% |
| 2023 Q3 | 142.11 Million CNY | -8.38% |
| 2022 Q2 | 132.89 Million CNY | 226.08% |
| 2022 FY | 126.35 Million CNY | 13930.88% |
| 2022 Q4 | 126.35 Million CNY | -6.29% |
| 2022 Q3 | 134.83 Million CNY | 1.46% |
| 2022 Q1 | 40.75 Million CNY | 4425.66% |
| 2021 Q4 | 900.52 Thousand CNY | -39.38% |
| 2021 FY | 900.52 Thousand CNY | -61.52% |
| 2021 Q3 | 1.48 Million CNY | -28.32% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q2 | 2.07 Million CNY | 0.0% |
| 2020 Q2 | - CNY | -100.0% |
| 2020 Q1 | 10 Million CNY | 0.0% |
| 2020 FY | 2.34 Million CNY | -76.6% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 10 Million CNY | 0.0% |
| 2019 FY | 10 Million CNY | -47.37% |
| 2018 Q3 | 19 Million CNY | 0.0% |
| 2018 Q4 | 19 Million CNY | 0.0% |
| 2018 FY | 19 Million CNY | 153.33% |
| 2017 FY | 7.5 Million CNY | 1701.15% |
| 2016 FY | 416.4 Thousand CNY | -36.88% |
| 2015 FY | 659.7 Thousand CNY | 0.0% |